Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Livapt 500mg Tablets | 105-Count | URSODEOXYCHOLIC ACID
Anti-Aging & LongevityPharma

Livapt 500mg Tablets | 105-Count | URSODEOXYCHOLIC ACID

$150

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse URSODEOXYCHOLIC ACID — 500mg per tablet, 105-count pack. Primary biliary cholangitis (PBC), cholestasis of pregnancy, gallstone dissolution (radiolucent stones), and non-alcoholic fatty liver disease (NAFLD). Key warning: Only effective for radiolucent (cholesterol) gallstones — not radiopaque. Monitor liver function regularly. Antacids containing aluminum/magnesium reduce absorption. Avoid in complete biliary obstruction.

SKU
VES-003723-LIVAPT-500MG-105TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Livapt 500mg (URSODEOXYCHOLIC ACID)?

Primary biliary cholangitis (PBC), cholestasis of pregnancy, gallstone dissolution (radiolucent stones), and non-alcoholic fatty liver disease (NAFLD).

How it Works

Replaces toxic hydrophobic bile acids, protects hepatocytes from bile acid injury, has anti-apoptotic and immune-modulating effects, and reduces cholesterol absorption.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
URSODEOXYCHOLIC ACID
Dose per Tablet
500MG
Pack Size
105 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Diarrhea (dose-dependent), nausea, abdominal discomfort. Generally very well tolerated long-term.

Safety Warnings

Only effective for radiolucent (cholesterol) gallstones — not radiopaque. Monitor liver function regularly. Antacids containing aluminum/magnesium reduce absorption. Avoid in complete biliary obstruction. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.